GlassScriptPhysician profile
Abraham Sadighi
NPI 1922092709
$3,655.33
in general payments reported to CMS, 2019-2025
25 companies · $91.32 in 2025
The $91.32 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,030 · 2020: $181 · 2021: $948 · 2022: $798 · 2023: $417 · 2024: $191 · 2025: $91.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $699.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $1,058.55 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Dryseal Flex Introducer Sheath, Gore Viabahn Vbx Balloon Expandable Endo |
| Cook Medical LLC | $413.63 | 2019-2023 | Zilver Ptx |
| Janssen Pharmaceuticals, INC | $401.61 | 2019-2024 | Xarelto |
| Endologix LLC | $317.85 | 2021 | |
| Medtronic, INC. | $259.78 | 2021-2025 | Endurant Iis, Chameleon, Venaseal |
| Boston Scientific Corporation | $218.03 | 2019-2025 | Enroute Transcarotid Neuroprotection System |
| Medtronic Vascular, INC. | $185.83 | 2019-2020 | |
| Silk Road Medical, INC. | $136.02 | 2021-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Penumbra, INC. | $88.10 | 2022-2023 | Smart Coil |
| Philips North America LLC | $85.54 | 2020-2022 | |
| Pfizer INC. | $80.23 | 2022-2023 | |
| Shockwave Medical, INC | $77.95 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Organogenesis INC. | $54.73 | 2021-2023 | Puraply |
| Bard Peripheral Vascular, INC. | $36.39 | 2023 | Venovo |
| Abbott Laboratories | $34.32 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $26.74 | 2022 | |
| Smith+Nephew, INC. | $24.95 | 2021 | |
| Kci USA, INC. | $23.66 | 2019 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $22.95 | 2019 | |
| Lemaitre Vascular, INC. | $22.60 | 2019 | |
| Inari Medical, INC. | $22.44 | 2022 | |
| Terumo Medical Corporation | $18.80 | 2021 | |
| Livanova USA, INC. | $16.50 | 2019 | |
| Cardiovascular Systems INC. | $15.34 | 2023 | Diamondback Peripheral |
| Cashflow Solutions, LLC | $12.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abraham Sadighi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.